Primary human papillomavirus screening for cervical cancer in the United States - US Food and Drug Administration approval, clinical trials, and where we are today

Ritu Nayar; Robert A. Goulart; Patricia G. Tiscornia-Wasserman; Diane Davis Davey

doi:10.1002/cncy.21480

Primary human papillomavirus screening for cervical cancer in the United States - US Food and Drug Administration approval, clinical trials, and where we are today

Ritu Nayar^*, Robert A. Goulart, Patricia G. Tiscornia-Wasserman, Diane Davis Davey

^*Corresponding author for this work

Pathology

Research output: Contribution to journal › Comment/debate › peer-review

16 Scopus citations

Original language	English (US)
Pages (from-to)	720-729
Number of pages	10
Journal	Cancer Cytopathology
Volume	122
Issue number	10
DOIs	https://doi.org/10.1002/cncy.21480
State	Published - Oct 1 2014

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/cncy.21480

Cite this

@article{d5d081b1fed448ba858d7979c56a9a71,

title = "Primary human papillomavirus screening for cervical cancer in the United States - US Food and Drug Administration approval, clinical trials, and where we are today",

author = "Ritu Nayar and Goulart, {Robert A.} and Tiscornia-Wasserman, {Patricia G.} and Davey, {Diane Davis}",

year = "2014",

month = oct,

day = "1",

doi = "10.1002/cncy.21480",

language = "English (US)",

volume = "122",

pages = "720--729",

journal = "Cancer Cytopathology",

issn = "1934-662X",

publisher = "Wiley-Blackwell",

number = "10",

}

Primary human papillomavirus screening for cervical cancer in the United States - US Food and Drug Administration approval, clinical trials, and where we are today. / Nayar, Ritu; Goulart, Robert A.; Tiscornia-Wasserman, Patricia G. et al.
In: Cancer Cytopathology, Vol. 122, No. 10, 01.10.2014, p. 720-729.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Primary human papillomavirus screening for cervical cancer in the United States - US Food and Drug Administration approval, clinical trials, and where we are today

AU - Nayar, Ritu

AU - Goulart, Robert A.

AU - Tiscornia-Wasserman, Patricia G.

AU - Davey, Diane Davis

PY - 2014/10/1

Y1 - 2014/10/1

UR - http://www.scopus.com/inward/record.url?scp=84921959466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921959466&partnerID=8YFLogxK

U2 - 10.1002/cncy.21480

DO - 10.1002/cncy.21480

M3 - Comment/debate

C2 - 25228434

AN - SCOPUS:84921959466

SN - 1934-662X

VL - 122

SP - 720

EP - 729

JO - Cancer Cytopathology

JF - Cancer Cytopathology

IS - 10

ER -

Primary human papillomavirus screening for cervical cancer in the United States - US Food and Drug Administration approval, clinical trials, and where we are today

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this